Search

everythinglearnresearchcommunity

for

Search:↓

Women may need different blood pressure guidelines than men for heart disease prevention.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Hair thinning causes stem cell loss through a process involving Piezo1, calcium, and TNF-α.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

Classical PCOS types A and B are most common and linked to higher health risks.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

A patch with curcumin-zinc can improve hair growth and health by delivering beneficial particles to the skin, increasing hair follicles, and reversing effects of a hair loss hormone.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Trichoscopy is a quick and easy way to diagnose most genetic hair problems without invasive methods.

Overweight women with PCOS are more likely to have excess male hormones.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Older mice have stiffer skin with less elasticity due to changes in collagen and skin structure, affecting aging and hair loss.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Baldness is linked to a higher risk of coronary artery disease, but not to its severity.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.